abiraterone acetate

abiraterone acetate (ABIRATERONE KRKA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

ABIRATERONE KRKA is a marketed brand name for abiraterone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

abiraterone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.